Sona Nanotech Inc. (SONA.CN)
CAD 0.28
(-3.51%)
CAD 0.28
(-3.51%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.03 CAD | 18.72% |
| 2022 | -0.04 CAD | 78.94% |
| 2021 | -0.17 CAD | -70.0% |
| 2020 | -0.10 CAD | -86.22% |
| 2019 | -0.05 CAD | 71.74% |
| 2018 | -0.19 CAD | -639.3% |
| 2017 | -0.03 CAD | 37.47% |
| 2016 | -0.04 CAD | -299.03% |
| 2015 | -0.01 CAD | 58.96% |
| 2014 | -0.03 CAD | -234.67% |
| 2013 | -0.01 CAD | 89.54% |
| 2012 | -0.07 CAD | -469.05% |
| 2011 | -0.01 CAD | 0.79% |
| 2010 | -0.01 CAD | 93.65% |
| 2009 | -0.20 CAD | -410.2% |
| 2008 | -0.04 CAD | -12.32% |
| 2007 | -0.03 CAD | -56.5% |
| 2006 | -0.02 CAD | -471.79% |
| 2005 | -0.00 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | -0.01 CAD | 8.14% |
| 2024 Q2 | -0.01 CAD | -11.69% |
| 2024 Q1 | -0.01 CAD | 0.0% |
| 2023 Q2 | -0.01 CAD | -10.53% |
| 2023 Q1 | -0.01 CAD | -142.54% |
| 2023 FY | - CAD | 18.72% |
| 2023 Q4 | -0.01 CAD | 13.48% |
| 2023 Q3 | -0.01 CAD | -41.27% |
| 2022 Q4 | 0.01 CAD | 215.52% |
| 2022 FY | - CAD | 78.94% |
| 2022 Q1 | -0.02 CAD | 17.54% |
| 2022 Q2 | -0.02 CAD | -15.52% |
| 2022 Q3 | -0.01 CAD | 42.29% |
| 2021 Q1 | -0.06 CAD | -6.49% |
| 2021 Q2 | -0.05 CAD | 17.09% |
| 2021 Q3 | -0.03 CAD | 31.22% |
| 2021 FY | - CAD | -70.0% |
| 2021 Q4 | -0.02 CAD | 37.39% |
| 2020 Q3 | -0.03 CAD | -105.84% |
| 2020 Q4 | -0.06 CAD | -96.81% |
| 2020 Q2 | -0.01 CAD | -140.35% |
| 2020 Q1 | -0.01 CAD | 16.18% |
| 2020 FY | - CAD | -86.22% |
| 2019 Q2 | -0.01 CAD | -27.69% |
| 2019 FY | - CAD | 71.74% |
| 2019 Q1 | -0.01 CAD | 92.65% |
| 2019 Q3 | -0.02 CAD | -197.59% |
| 2019 Q4 | -0.01 CAD | 72.47% |
| 2018 Q3 | -0.00 CAD | 73.97% |
| 2018 Q1 | -0.01 CAD | 77.78% |
| 2018 FY | - CAD | -639.3% |
| 2018 Q4 | -0.09 CAD | -4552.63% |
| 2018 Q2 | -0.01 CAD | -4.29% |
| 2017 Q2 | -0.00 CAD | -160.0% |
| 2017 FY | - CAD | 37.47% |
| 2017 Q4 | -0.03 CAD | -730.0% |
| 2017 Q3 | 0.01 CAD | 933.33% |
| 2017 Q1 | 0.00 CAD | 130.3% |
| 2016 Q2 | -0.00 CAD | -112.5% |
| 2016 FY | - CAD | -299.03% |
| 2016 Q3 | -0.03 CAD | -861.76% |
| 2016 Q4 | -0.00 CAD | 89.91% |
| 2016 Q1 | -0.00 CAD | 65.96% |
| 2015 Q3 | -0.00 CAD | 10.0% |
| 2015 Q2 | -0.00 CAD | -42.86% |
| 2015 Q1 | -0.00 CAD | 89.23% |
| 2015 FY | - CAD | 58.96% |
| 2015 Q4 | -0.00 CAD | -161.11% |
| 2014 Q4 | -0.01 CAD | -19.27% |
| 2014 Q3 | -0.01 CAD | -10800.0% |
| 2014 Q2 | -0.00 CAD | 90.91% |
| 2014 FY | - CAD | -234.67% |
| 2014 Q1 | -0.00 CAD | -10.0% |
| 2013 Q3 | -0.00 CAD | -9.52% |
| 2013 FY | - CAD | 89.54% |
| 2013 Q2 | -0.00 CAD | 4.55% |
| 2013 Q4 | -0.00 CAD | 56.52% |
| 2013 Q1 | -0.00 CAD | 12.0% |
| 2012 Q1 | -0.07 CAD | -2584.0% |
| 2012 FY | - CAD | -469.05% |
| 2012 Q4 | -0.00 CAD | -4.17% |
| 2012 Q3 | -0.00 CAD | 44.19% |
| 2012 Q2 | -0.00 CAD | 93.59% |
| 2011 FY | - CAD | 0.79% |
| 2011 Q2 | -0.00 CAD | 9.38% |
| 2011 Q1 | -0.00 CAD | -6.67% |
| 2011 Q3 | -0.00 CAD | -27.59% |
| 2011 Q4 | -0.00 CAD | 32.43% |
| 2010 Q2 | -0.00 CAD | 10.81% |
| 2010 Q1 | -0.00 CAD | 84.26% |
| 2010 Q4 | -0.00 CAD | -11.11% |
| 2010 Q3 | -0.00 CAD | 18.18% |
| 2010 FY | - CAD | 93.65% |
| 2009 Q1 | -0.01 CAD | 76.83% |
| 2009 FY | - CAD | -410.2% |
| 2009 Q2 | -0.17 CAD | -1689.47% |
| 2009 Q4 | -0.02 CAD | -434.09% |
| 2009 Q3 | -0.00 CAD | 97.41% |
| 2008 Q2 | 0.02 CAD | 745.16% |
| 2008 Q4 | -0.04 CAD | -247.46% |
| 2008 Q3 | -0.01 CAD | -159.0% |
| 2008 FY | - CAD | -12.32% |
| 2008 Q1 | -0.00 CAD | 73.5% |
| 2007 Q4 | -0.01 CAD | -44.44% |
| 2007 Q3 | -0.01 CAD | -3.85% |
| 2007 Q2 | -0.01 CAD | -47.17% |
| 2007 Q1 | -0.01 CAD | -39.47% |
| 2007 FY | - CAD | -56.5% |
| 2006 FY | - CAD | -471.79% |
| 2006 Q2 | -0.05 CAD | 0.0% |
| 2006 Q4 | -0.00 CAD | -26.67% |
| 2006 Q3 | -0.00 CAD | 93.75% |
| 2006 Q1 | - CAD | 0.0% |
| 2005 FY | - CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| BioMark Diagnostics Inc. | -0.02 CAD | -74.251% |
| Izotropic Corporation | -0.03 CAD | -0.345% |